<Disease><Name>HYPEROXALURIA, PRIMARY, TYPE I, PH1</Name><Synonym>OXALOSIS I, GLYCOLICACIDURIA</Synonym><OMIM><Number>259900</Number><URL>http://omim.org/entry/259900</URL></OMIM><Orphanet><Number>93598</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=93598</URL></Orphanet><Protein><Number>Serine--pyruvate aminotransferase</Number><URL>http://www.uniprot.org/uniprot/P21549</URL></Protein><ExPASy><Number>2.6.1.44</Number><URL>http://enzyme.expasy.org/EC/2.6.1.44</URL></ExPASy><Gene>2q37.3</Gene><ICD>E74.8</ICD><Summary>rare (330 cases) ;autosomal recessive ;peroxisomal disorder</Summary><Symptoms><symtomp><id>3786</id><symptom>acrocyanosis</symptom><category>SKIN</category></symtomp><symtomp><id>2288</id><symptom>bone fractures / pathological fractures</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>3870</id><symptom>calcinosis cuti</symptom><category>SKIN</category></symtomp><symtomp><id>2104</id><symptom>cardiomyopathy</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2165</id><symptom>cyanosis</symptom><category>GENERAL TOPICS | SKIN</category></symtomp><symtomp><id>1883</id><symptom>ECG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>1882</id><symptom>growth retardation, poor growth</symptom><category>GENERAL TOPICS | GENERAL TOPICS</category></symtomp><symtomp><id>2274</id><symptom>hematuria</symptom><category>GENERAL TOPICS | GENITOURINARY TRACT</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2362</id><symptom>hyperparathyreoidism, secondary</symptom><category>ENDOCRINE SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>2275</id><symptom>infections (urinary tract)</symptom><category>GENITOURINARY TRACT | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>2359</id><symptom>myocarditis</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1922</id><symptom>nephrocalcinosis</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1739</id><symptom>optic atrophy</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2361</id><symptom>osteodystrophy / osteodystrophy, renal</symptom><category>GENITOURINARY TRACT | SKELATAL DEFECT | SKELETAL DEFECT</category></symtomp><symtomp><id>2358</id><symptom>pain, bones or joints / pain bones</symptom><category>GENERAL TOPICS | SKELATAL DEFECT | SKELETAL DEFECT</category></symtomp><symtomp><id>2027</id><symptom>pancytopenia</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2360</id><symptom>peripheral gangrene</symptom><category>CARDIOVASCULAR SYSTEM | SKIN</category></symtomp><symtomp><id>1939</id><symptom>peripheral neuropathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3988</id><symptom>renal colic</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2461</id><symptom>renal failure, acute/chronic</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>4097</id><symptom>renal failure, chronic</symptom><category /></symtomp><symtomp><id>2375</id><symptom>retinopathy</symptom><category>EYES</category></symtomp><symtomp><id>2006</id><symptom>skin defects</symptom><category>GENERAL TOPICS | SKIN</category></symtomp><symtomp><id>2236</id><symptom>urolithiasis, nephrolithiasis, kidney stones</symptom><category>GENITOURINARY TRACT</category></symtomp></Symptoms><Metabolites><metabolite><id>1701</id><name>Urea</name><specimen>urine</specimen><value /><min>17.40</min><max>49.10</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1724</id><name>Glycolic acid</name><specimen>urine</specimen><value>increased</value><min>190.00</min><max>480.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1752</id><name>Creatinine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>12.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1864</id><name>Creatinine</name><specimen>urine</specimen><value>increased</value><min>4.95</min><max>24.54</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>780</id><name>Alanine-glyoxylate-aminotransferase</name><specimen>fibroblasts</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>823</id><name>Creatinine</name><specimen>urine</specimen><value>decreased</value><min>8.00</min><max>20.00</max><unit>mg/kg/24h</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>28</id><name>Creatinine</name><specimen>serum</specimen><value>decreased</value><min>27.00</min><max>88.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>304</id><name>Creatinine</name><specimen>serum</specimen><value>decreased</value><min>18.00</min><max>35.00</max><unit>&#181;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>305</id><name>Creatinine</name><specimen>serum</specimen><value>decreased</value><min>27.00</min><max>62.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>306</id><name>Creatinine</name><specimen>serum</specimen><value>decreased</value><min>53.00</min><max>106.00</max><unit>&#181;mol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>834</id><name>Creatinine</name><specimen>plasma</specimen><value>normal/inc</value><min>0.20</min><max>0.40</max><unit>mg/dl</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1200</id><name>Creatinine</name><specimen>cerebrospinal fluid</specimen><value>normal/inc</value><min>27.00</min><max>70.00</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>116</id><name>Glycolic acid</name><specimen>urine</specimen><value>increased</value><min>48.00</min><max>164.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>505</id><name>Glycolic acid</name><specimen>urine</specimen><value>increased</value><min>9.00</min><max>72.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>533</id><name>Glycolic acid</name><specimen>urine</specimen><value>increased</value><min>32.00</min><max>160.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>534</id><name>Glycolic acid</name><specimen>urine</specimen><value>increased</value><min>23.00</min><max>146.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>535</id><name>Glycolic acid</name><specimen>urine</specimen><value>increased</value><min>3.70</min><max>122.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>477</id><name>Glycolic acid</name><specimen>plasma</specimen><value>increased</value><min>9.00</min><max>42.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>478</id><name>Glycolic acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>5.00</min><max>250.00</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>117</id><name>Glyoxylic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>11.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1345</id><name>Glyoxylic acid</name><specimen>urine</specimen><value>increased</value><min>    </min><max>20.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1317</id><name>Oxalic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>125.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>115</id><name>Oxalic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>70.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>1520</id><name>Oxalic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>160.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>1519</id><name>Oxalic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>174.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>1547</id><name>Oxalic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>54.00</max><unit>mmol/mol creatinine</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>2042</id><name>Urea</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>29</id><name>Urea</name><specimen>serum</specimen><value>increased</value><min>5.00</min><max>15.00</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>296</id><name>Urea</name><specimen>serum</specimen><value>increased</value><min>1.80</min><max>6.40</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>297</id><name>Urea</name><specimen>serum</specimen><value>increased</value><min>1.80</min><max>6.40</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>298</id><name>Urea</name><specimen>serum</specimen><value>increased</value><min>2.50</min><max>6.40</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>299</id><name>Urea</name><specimen>serum</specimen><value>increased</value><min>1.10</min><max>9.00</max><unit>mmol/l</unit><age>premature</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7322</id><title>Development and Validation of a New Gas Chromatography-Tandem Mass Spectrometry Method for the Measurement of Enrichment of Glyoxylate Metabolism Analytes in Hyperoxaluria Pat</title><author>van Harskamp D,</author><journal>Anal Chem</journal><year>2020</year><book /><volume>92</volume><number>2</number><pages>1826-1832</pages><co_aut>et al.</co_aut></literature><literature><id>8060</id><title>Investigational Therapies for Primary Hyperoxaluria</title><author>Kletzmayr A,</author><journal>Bioconjug Chem</journal><year>2020</year><book /><volume>31</volume><number>7</number><pages>1696-1707</pages><co_aut>Ivarsson ME, Leroux J-C</co_aut></literature><literature><id>4654</id><title>Unusual clinical outcome of primary Hyperoxaluria type 1 in Tunisian patients carrying 33_34InsC mutation</title><author>Mbarek IB,</author><journal>BMC Nephrol</journal><year>2017</year><book /><volume>18</volume><number>1</number><pages>195</pages><co_aut>et al.</co_aut></literature><literature><id>4655</id><title>Clinical spectrum of primary hyperoxaluria type 1: Experience of a tertiary center</title><author>Soliman NA,</author><journal>Nephrol Ther</journal><year>2017</year><book /><volume>13</volume><number>3</number><pages>176-182</pages><co_aut>et al.</co_aut></literature><literature><id>5720</id><title>Type 1 primary hyperoxaluria in a male infant</title><author>Waddell B,</author><journal>Kidney Res Clin Pract</journal><year>2017</year><book /><volume>36</volume><number>4</number><pages>393</pages><co_aut>McKenney D</co_aut></literature><literature><id>5722</id><title>Primary Hyperoxaluria Type 1</title><author>Milliner DS,</author><journal>GeneReviews&#174; [Internet]</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>5723</id><title>Primary Hyperoxaluria</title><author>Jiang D,</author><journal>N Engl J Med</journal><year>2017</year><book /><volume>376</volume><number>15</number><pages>e33</pages><co_aut>Geng H</co_aut></literature><literature><id>4653</id><title>Simultaneous analysis of urinary metabolites for preliminary identification of primary hyperoxaluria</title><author>Clifford-Mobley O,</author><journal>Ann Clin Biochem</journal><year>2016</year><book /><volume>53</volume><number>4</number><pages>485-494</pages><co_aut>Hewitt L2, Rumsby G</co_aut></literature><literature><id>4656</id><title>DETAILED CLINICAL PHENOTYPING OF OXALATE MACULOPATHY IN PRIMARY HYPEROXALURIA TYPE 1 AND REVIEW OF THE LITERATURE</title><author>Derveaux T,</author><journal>Retina</journal><year>2016</year><book /><volume>36</volume><number>11</number><pages>2227-2235</pages><co_aut>et al.</co_aut></literature><literature><id>4651</id><title>An update on primary hyperoxaluria</title><author>Hoppe B</author><journal>Nat Rev Nephrol</journal><year>2012</year><book /><volume>8</volume><number>8</number><pages>467-475</pages><co_aut /></literature><literature><id>2137</id><title>Molecular aetiology of primary hyperoxaluria type 1</title><author>Danpure CJ</author><journal>Nephron Exp Nephrol</journal><year>2004</year><book /><volume>98</volume><number>2</number><pages>e39-44</pages><co_aut /></literature><literature><id>2138</id><title>Crystal structure of alanine:glyoxylate aminotransferase and the relationship between genotype and enzymatic phenotype in prima</title><author>Zhang X</author><journal>J Mol Biol</journal><year>2003</year><book /><volume>331</volume><number>0</number><pages>643-652</pages><co_aut>et al.</co_aut></literature><literature><id>1182</id><title>Primary hyperoxaluria type 1: improved outcome with timely liver transplantation: a single-center report of 36 children</title><author>Shapiro R</author><journal>Transplantation 2001 Aug 15;72(3):428-32</journal><year>2001</year><book /><volume>72</volume><number>0</number><pages>428-432</pages><co_aut>et al.</co_aut></literature><literature><id>834</id><title>Primary hyperoxaluria</title><author>Danpure CJ</author><journal>The Metabolic and Molecular Bases of Inherited Disease on CD-ROM; The McGraw-Hill Companies</journal><year>1997</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Purdue PE</co_aut></literature><literature><id>587</id><title>Persistent glycolic aciduria in a health child with normal alanine-glyoxylate aminotransferase activity</title><author>Craigen WJ</author><journal>J Inherit Metab Dis</journal><year>1996</year><book /><volume>19</volume><number>0</number><pages>793-794</pages><co_aut /></literature><literature><id>835</id><title>Hyperoxaluria with hyperglycoluria not due to alanine:glyoxylate aminotransferase defect: a novel type of primary hyperoxaluria&lt;</title><author>van Acker KJ</author><journal>Kidney Int</journal><year>1996</year><book /><volume>50</volume><number>0</number><pages>1747-1752</pages><co_aut>et al.</co_aut></literature><literature><id>107</id><title>Primary hyperoxaluria</title><author>Danpure CJ</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>0</number><pages>2385-2424</pages><co_aut>Purdue PE</co_aut></literature><literature><id>232</id><title>Clinical approach to inherited peroxisomal disorders</title><author>Poggi-Travert F</author><journal>J Inher Met Dis Suppl</journal><year>1995</year><book /><volume>18</volume><number>0</number><pages>1-18</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>